-
RPS warns against including medicines in personal budgets
30 Apr 13 | 15.11 | England
Pharmacy’s professional body has warned against including medicines in personal health budgets...
more > -
Initiative aims to improve discharge information
29 Apr 13 | 16.35 | England
An electronic system that allows hospital pharmacists to send medicines information to community pharmacists is being developed by... more >
-
EU list of “black triangle” medicines published
29 Apr 13 | 16.24 | EU
The European Medicines Agency has published its initial list of medicines subject to additional monitoring as part of the new EU-wide more >
-
PCC clarifies service commissioning arrangements
29 Apr 13 | 15.40 | England
Smoking cessation and emergency hormonal contraception services should no longer be referred to as enhanced services... more >
-
UK spends less on new medicines than other developed countries
26 Apr 13 | 15.45 | England EU International Northern Ireland Scotland Wales
Investment in new medicines is falling as a proportion of total NHS spend — a “crude” savings approach that may be damaging patient care... more >
-
MMR vaccination programme to target one million
25 Apr 13 | 16.56 | England Scotland Wales
One million children and teenagers in England are to be targeted in a national MMR vaccination catch-up programme, announced today... more >
-
Community pharmacy champion funding to continue
24 Apr 13 | 15.27 | Scotland
Funding for community pharmacist practitioner champions in Scotland will be continued in 2013-14...
more > -
All change for commissioning and medicines management pharmacists
24 Apr 13 | 15.11 | England
There are mixed feelings among pharmacists about what the recent NHS reforms in England have meant for their working practices. Debbie Andalo spoke to some of them more >
-
Abatacept approved by NICE with patient access agreement
24 Apr 13 | 9.26 | England Wales
Abatacept (Orencia) can now be used for the treatment of some patients with rheumatoid arthritis in England and Wales after the Department... more >
-
NICE confirms omalizumab advice
24 Apr 13 | 9.22 | England Wales
Omalizumab (Xolair) can now be prescribed within the NHS in England and Wales as an option for adults and children over six years old with... more >

